MYC and neoplasm: Our analysis indicates that SNAPC2 activates several key oncogenic pathways, including MYC, E2F, Notch, and PI3K signaling pathways, all of which are closely associated with tumor proliferation, metabolic reprogramming, and malignant transformation.